A large number, nearly 1000, gene therapy clinical trials have been or are being conducted worldwide, and two-thirds of these are for cancer.1 While the technology itself is still evolving, gene therapy is particularly suitable for cancer, since most patients with cancer who are eligible for clinical trials, are terminal with poor prognosis and dismal outcomes due to failing conventional treatment